Oxidative burst measurement in patients treated with cytostatics: Influence of G-CSF and role as a prognostic factor

Annals of Hematology

Volumn 79, Issue 4, 2000, Pages 187-197

  Volk, J ^a   Kleine, H D ^a   Buthmann, U ^a   Freund, M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cytokines; Flow cytometry; Infections; Neutrophils; Oxidative burst

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSTATIC AGENT; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TENIPOSIDE; VINCRISTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOSTASIS; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LEUKOPENIA; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY BURST;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CYTARABINE; DEXAMETHASONE; ESCHERICHIA COLI; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; MELPHALAN; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PROGNOSIS; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE;

EID: 0034005805     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050578     Document Type: Article

References (56)

1. Alexander JW, Stinnett JD, Ogle CK, Ogle JD, Morris MJ (1979) A comparison of immunologic profiles and their influence on bacteremia in surgical patients with a high risk of infection. Surgery 1:94-104
2. Babior BM (1978) Oxygen-dependent microbial killing by phagocytes. N Engl J Med 12:659-668
3. Baggiolini M, Wymann MP (1990) Turning on the respiratory burst. Trends Biochem Sci 15:69-72
4. Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide 1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049
5. Balazovich KJ, Almeida HI, Boxer LA (1991) Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms. J Lab Clin Med 6:576-584
6. Cairo MS, Plunkett JM, Mauss D, Van de ven C (1990) Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis. Blood 9:1788-1794
7. Carr R, Whittall T, Modi N (1997) The effect of neutrophil number, phenotype and function of five-day prophylactic administration of GM-CSF to preterm neonates. Blood 10 [Suppl 1]: abstract 768
8. Cinco M, Murgia R, Pertiicaria S, Presani G (1994) Simultaneous measurement by flow cytometry of phagocytosis and metabolic burst induced in phagocytic cells in whole blood by Borrelia burgdorferi. Microbiol Lett 122:187-194
9. de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RHJ, von dem Borne AEGK (1994) Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 11:3885-3894
10. Diamond RD, Clark RA, Haudenschild CC (1980) Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J Clin Invest 66:908-917
11. Elbim C, Bailly S, Chollet-Martin S, Hakim J, Gougerot-Pouidalo MA (1994) Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun 6:2195-2201
12. Fröhlich D, Rothe G, Schwall B, Schmid P, Schmitz G, Taeger K, Hobbhahn J (1997) Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. Br J Anaesth 78:718-723
13. Gessler P, Nebe T, Birle A, Haas N, Kachel W (1996) Neutrophil respiratory burst in term and preterm neonates without signs of infection and in those with increased levels of C-reactive protein. Pediatr Res 5:843-848
14. Gessler P, Nebe T, Birle A, Mueller W, Kachel W (1996) A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst. Intensive Care Med 22:252-258
15. Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS (1994) A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood 5:1427-1433
16. Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A (1992) Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α. J Immunol 3:918-924
17. Heine J, Leuwer M, Scheinichen D, Arseniev L, Jaeger K, Piepenbrock S (1996) Flow cytometry evaluation of the in vitro influence of four i.v. anaesthetics on respiratory burst of neutrophils. Br J Anaesth 77:387-392
18. Höglund M, Hakansson L, Venge P (1997) Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers. Eur J Haematol 58:195-202
19. Hübel K, Hegener K, Schnell R, Diehl V, Engert A (1997) Suppressed neutrophil function before chemotherapy in patients with acute myelogenous leukaemia correlates with severe infections after treatment. Onkologie 20 [Suppl 1]: abstract 488
20. Hübet K, Schäfer H, Mansmann G, Lentini S, Hölscher A H, Diehl V, Engert A (1997) A phase II study of perioperative treatment with granulocyte-colony-stimulating factor (G-CSF) in patients with esophageal cancer: enhanced neutrophil function and reduced infectious complications after esophagectomy. Onkologie 20 [Suppl 1]: abstract 13
21. Humphreys JM, Rugman FP, Davies JM, Mimnagh P, Hart CA, Edwards SW (1991) Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in vitro and in vivo following chemotherapy and autologous bone marrow transplantation. J Clin Lab Immunol 34:55-61
22. Kerst JM, de Haas M, van der School CE, Slaper-Cortenbach ICM, Kleijer M, Von dem Borne AEGK, van Oers RHJ (1993) Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 11:3265-3272
23. Khwaja A, Carver JE, Linch DC (1992) Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor-a in the priming of the neutrophil respiratory burst. Blood 3:745-753
24. Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P (1996) Granulocyte functions in children with cancer are differentially sensitive to the toxic effect of chemotherapy. Pediatr Res 39:835-842
25. Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P (1996) Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colonystimulating factor in vitro. J Infect Dis 174:800-805
26. Levitz SM (1992) Overview of host defenses in fungal infections. Clin Infect 14 [Suppl 1]: S37-S42
27. Liles WC, Huang JE, van Burik JAH, Bowden RA, Dale DC (1997) Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 175:1012-1015
28. Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, Mertelsmann R (1989) Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 74:2644-2651
29. Marzzullo L, Souza LC, Campa A (1997) Effect of amphotericin B associated with a lipid emulsion on the oxidative burst of human polymorphonuclear leukocytes. Gen Pharmacol 2:203-227
30. Miyagawa B, Klingemann HG (1997) Phagocytosis and burst activity of granulocytes and monocytes after stem cell transplantation. J Lab Clin Med 129:634-637
31. Model MA, KuKuruga MA, Todd III RF (1997) A sensitive flow cytometry method for measuring the oxidative burst. J Immunol Methods 202:105-111
32. Nespoli A (1994) Role of haematopoietic growth factors in the pathophysiology of infection associated to injury. Forum 4.2:199-208
33. Okuda A, Kubota M, Sawada M, Koishi S, Kataoka A. Bessho R, Usami I, Lin YW, Adachi S, Furusho K (1996) Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor. J Cell Physiol 168:183-187
34. Pajkrt D, Manten A, van der Poll T. Tiel-van Buul MMC, Jansen J, Wouter ten Cate J, Van Deventer SJH (1997) Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 4:1415-1424
35. Perticarari S, Presani G, Banfi E (1994) A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 170:117-124
36. Pilot MA (1994) Macrolides in roles beyond antibiotic therapy. Br J Surg 81:1423-1429
37. Oiao X, Smith S, Unverzagt K, Martinsori J, Loudovaris M, Berger C, van Epps D, Bender J (1996) Morphology, granule enzymes, proliferative potential and function of in vitro derived neutrophil precursors. Blood 88 [Suppl 1]: abstr 623
38. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ (1992) Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-γ. J Infect Dis 166:668-673
39. Rothe G, Valet G (1994) Flow cytometry assays of oxidative burst activity in phagocytes. Methods Enzymol 233:539-548
40. Sato N, Kashima K, Tanaka Y, Shimizu H, Mori M (1997) Effect of granulocyte colony-stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients. Diabetes 46:133-137
41. Silver GM, Gamelli RL, O'Reilly M (1989) The beneficial effect of granulocyte colony-stimulating factor (GCSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery 2:452-456
42. Sklar LA, Hyslop PA, Oades ZG, Omann GM, Jesaitis AJ, Painter RG, Cochrane CG (1985) Signal transduction and ligand-receptor dynamics in the human neutrophil. J Biol Chem 21:11461-11467
43. Smith JA, Weidemann MJ (1993) Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 162:261-268
44. Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K (1997) Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 11:466-478
45. Sullivan GW, Carper HT, Mandell GL (1993) The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 7:1863-1870
46. Sullivan GW, Gelrud AK, Carper HAT, Mandell GL (1996) Interaction of tumor necrosis factor-alpha and granulocyte colony-stimulating factor on neutrophil apoptosis, receptor expression, and bactericidal function. Proc Assoc Am Physicians 108:455-466
47. Tennenberg SD, Solonikin JS (1988) Neutrophil activation in sepsis. Arch Sur 123:171-175
48. Timoshenko AV, Kayser K, Drings P, Kolb G, Havemann K, Gabius HJ (1993) Modulation of lectin-triggered superoxide release from neutrophils of tumor patients with and without chemotherapy. Anticancer Res 13:1789-1792
49. van der Nat JM, Beijnen JH, Driebergen RJ, Thart LA, van Dijk H, Underberg WJ, Labadie RP (1988) In vitro immunosuppressive activities of recently developed anthracycline cytostatics. Anticancer Res 8:489-493
50. van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BG (1996) Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Methods 191:187-196
51. Volk J, Kleine H-D, Buthmann U, Freund M (1997) Effects of cytostatics and G-CSF on granulocytes in vivo determined by oxidative burst measurement ex vivo. Onkologie 20 [Suppl 1]: abstract 281
52. Weisbart R H, Golde D W, Gasson J C (1986) Biosynthetic human G-CSF modulates the number and affinity of neutrophil f-met-leu-phe receptors. J Immunol 11:3584-3587
53. Wenisch C, Parschalk B, Hasenhündl M, Griesmacher A, Graninger W (1995) Polymorphonuclear leukocyte dysregulation in patients with gram-negative septicaemia assessed by flow cytometry. Eur J Clin Invest 25:418-424
54. Wenisch C, Parschalk B, Hasenhündl M, Wiesinger E, Graninger W (1995) Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections. Antimicrob Agents Chemother 3:672-676
55. Wenisch C, Parschalk B, Zedtwitz-Liebenstein K, Weihs A, el Menyawi I, Graninger W (1996) Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. Antimicrob Agents Chemother 9:2039-2042
56. Wiltschke C, Krainer M, Nanut M, Wagner A, Linkesch W, Zielinski CC (1995) In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity. J Interferon Cytokine Res 15:249-253